Physician profile
Eric Johnson
NPI 1245201169
$905.75
in general payments reported to CMS, 2019-2025
14 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.07 · 2021: $50.00 · 2022: $37.45 · 2023: $232 · 2024: $221 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $796.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $278.41 | 2024-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $182.73 | 2019-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $143.59 | 2025 | Cobenfy |
| Glaxosmithkline, LLC. | $77.21 | 2021-2023 | Nucala |
| Abbvie INC. | $37.45 | 2022 | |
| Convatec INC. | $30.99 | 2024 | |
| Genzyme Corporation | $25.82 | 2023 | |
| Olympus America INC. | $22.88 | 2023 | |
| Daiichi Sankyo INC. | $20.11 | 2023 | Injectafer |
| Medtronic, INC. | $20.10 | 2023 | Stealthstation S8 Platform |
| Gilead Sciences, INC. | $18.94 | 2023 | |
| Genentech USA, INC. | $18.00 | 2024 | Xolair |
| Orthofix Medical, INC. | $15.08 | 2024 | Physio-Stim |
| Acclarent, INC | $14.44 | 2023 | Relieva Spinplus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.